An interview with José Clemente: “Early life changes in microbiota as a result of C-Section may be responsible for diseases in children later on”
During the 5th Gut Microbiota for Health World Summit 2016 José Clemente, assistant professor at Icahn School of Medicine at Mount Sinai in New York City, talk about the importance of gut microbiota at early life.
Researcher José Clemente, assistant professor at Icahn School of Medicine at Mount Sinai in New York City, investigates whether we can revert the effects of an abnormal microbial colonisation after, for instance, a C-section. He attended the 5th Gut Microbiota for Health World Summit 2016, held in Miami and we had the opportunity to interview him and talk about the importance of gut microbiota at early life. We hope you enjoy the interview.
Beyond genetics and lifestyle, the gut microbiome is now emerging as an important factor in cancer progression and treatment response. This raises an important question: could understanding and targeting this ecosystem transform the way we treat cancer?
Bifidobacteria are increasingly studied as a marker of gut health across a lifetime. In this interview, microbiome researcher Sudarshan Shetty explains what shapes them, how they change with age, and what diet can do.
Crohn’s disease is an inflammatory bowel disease linked to an imbalance in the gut microbiome. Now, researchers at McMaster University have found in mice a way to target and 'turn off' only the bad gut bacteria using specially trained, precision viruses. This breakthrough paves the way for treatments tailored to each patient.
